StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Allergan (AGN) in Final Stages of Selling Antibiotics Divisions, Plans to Keep Women's Health Unit - Bloomberg, Citing Conf. Call
January 29, 2019 8:43 AM
Allergan (NYSE: AGN) in Final ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Management Comments
Mergers and Acquisitions
Next Articles
Allergen (AGN) PT Lowered to $200 at Mizuho Securities
January 30, 2019 8:21 AM
Allergen (AGN) PT Lowered to $181 at Raymond James
January 30, 2019 7:19 AM
Allergan (AGN) Tops Q4 EPS by 14c, Offers Q1 and FY Guidance, Approves $2B Buyback
January 29, 2019 7:04 AM
Allergan Reports Fourth Quarter and Full-Year 2018 Financial Results
January 29, 2019 7:01 AM